-
EP3169316
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3169316
| EP3169316 - COMPOSITIONS AND METHODS FOR REDUCING OVERDOSE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 19.02.2021 Database last updated on 19.10.2024 | |
| Former | Grant of patent is intended Status updated on 01.06.2020 | ||
| Former | Request for examination was made Status updated on 21.04.2017 | ||
| Former | The international publication has been made Status updated on 08.02.2017 | Most recent event Tooltip | 19.02.2021 | Application deemed to be withdrawn | published on 24.03.2021 [2021/12] | Applicant(s) | For all designated states Odidi, Isa 56 Fifeshire Road Toronto, ON M2L 2G8 / CA | [2017/21] | Inventor(s) | 01 /
see applicant ... | [2017/21] | Representative(s) | Appleyard Lees IP LLP 15 Clare Road Halifax HX1 2HY / GB | [2017/21] | Application number, filing date | 15831511.9 | 19.06.2015 | [2017/21] | WO2015CA50567 | Priority number, date | US201462024940P | 15.07.2014 Original published format: US 201462024940 P | [2017/21] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016023108 | Date: | 18.02.2016 | Language: | EN | [2016/07] | Type: | A1 Application with search report | No.: | EP3169316 | Date: | 24.05.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 18.02.2016 takes the place of the publication of the European patent application. | [2017/21] | Search report(s) | International search report - published on: | CA | 18.02.2016 | (Supplementary) European search report - dispatched on: | EP | 02.01.2018 | Classification | IPC: | A61K9/28, A61K9/20, A61K9/16 | [2018/04] | CPC: |
A61K9/5026 (EP,US);
A61K47/02 (US);
A61K31/00 (US);
A61K31/135 (EP,US);
A61K31/167 (US);
A61K31/192 (EP,US);
A61K31/197 (EP,US);
A61K31/366 (US);
A61K31/37 (EP,US);
A61K31/4402 (EP,US);
A61K31/4439 (US);
A61K31/4458 (US);
A61K31/4748 (EP,US);
A61K31/485 (EP,US);
A61K31/515 (EP,US);
A61K31/5513 (EP,US);
A61K31/616 (US);
A61K47/12 (US);
A61K47/183 (US);
A61K47/20 (US);
A61K47/26 (US);
A61K47/32 (US);
A61K47/36 (US);
A61K47/38 (US);
A61K9/1623 (EP,US);
A61K9/1652 (EP,US);
A61K9/2013 (US);
A61K9/2018 (EP,US);
A61K9/2027 (EP,US);
A61K9/2054 (EP,US);
A61K9/2059 (EP,US);
A61K9/2086 (EP,US);
A61K9/209 (EP,US);
A61K9/28 (US);
A61K9/2813 (EP,US);
A61K9/282 (US);
A61K9/2846 (EP,US);
A61K9/2853 (US);
A61K9/2866 (EP,US);
A61K9/2886 (EP,US);
A61K9/4808 (US);
A61K9/485 (US);
A61K9/4866 (US);
A61K9/4891 (US);
A61K9/501 (US);
A61K9/5015 (US);
A61K9/5031 (US);
A61P25/04 (EP);
A61P25/30 (EP);
A61P25/36 (EP);
A61K9/2031 (US);
A61K9/4858 (US)
(-)
|
| Former IPC [2017/21] | A61K9/52, A61K47/00, A61P25/30 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/21] | Title | German: | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR REDUZIERUNG EINER ÜBERDOSIS | [2017/21] | English: | COMPOSITIONS AND METHODS FOR REDUCING OVERDOSE | [2017/21] | French: | COMPOSITIONS ET PROCÉDÉS POUR RÉDUIRE UNE SURDOSE | [2017/21] | Entry into regional phase | 08.02.2017 | National basic fee paid | 08.02.2017 | Search fee paid | 08.02.2017 | Designation fee(s) paid | 08.02.2017 | Examination fee paid | Examination procedure | 08.02.2017 | Examination requested [2017/21] | 08.02.2017 | Date on which the examining division has become responsible | 26.06.2018 | Amendment by applicant (claims and/or description) | 02.06.2020 | Communication of intention to grant the patent | 13.10.2020 | Application deemed to be withdrawn, date of legal effect [2021/12] | 03.11.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2021/12] | Fees paid | Renewal fee | 27.06.2017 | Renewal fee patent year 03 | 21.06.2018 | Renewal fee patent year 04 | 21.06.2019 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 30.06.2020 | 06 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [E]WO2015120201 (KASHIV PHARMA LLC [US]) [E] 1-29 * paragraphs [0010] , [0011] , [0032] , [0085]; example III; tables 7-11,14 *; | [X]WO2012112952 (QRXPHARMA LTD [AU], et al) [X] 1-29 * figures 1,2,34; example 13; tables 39,40 * | International search | [A]US2013295170 (DORDUNOO STEPHEN [US]) [A] 0; | [A]US2008090771 (MONCRIEF JAMES S [US]) [A] 0; | [A]US4175119 (PORTER GARRY L [US]) [A] 0; | [A]US2013034503 (HOWARD WILLIAM WAYNE [US], et al) [A] 0; | [A]WO2011066980 (HERMANN LARS HOLGER [CH]) [A] 0 |